INSUBCONTINENT EXCLUSIVE:
Also participating are Doberman and Privilege Ventures (an investor in Ava), plus a number of angel investors including Josefin Landgard
CEO Mohamed Taha, is to make access to fertility treatment more affordable and accessible by using AI and robotics technology to assist in
sperm and egg quality analysis, selection and fertilization to reduce costs for clinics
roadmap is completed, product wise, is to look at sperm, look at eggs, look at data and ensure that the woman or the couple get precise
His doctor suggested freezing his sperm as a precaution against deterioration in case he wanted to father a child in the future, so he
started having regular sperm tests
healthy baby or could result in a miscarriage
as a weekend project during their PhDs
Taha initially trained as an electrical engineer before going on to do a PhD in nanotechnology, investigating new and affordable materials
It was the microscopes and robotic arms that he and his co-founder Daniel Thomas, were using in the labs to examine nanoparticles and select
specific particles for insertion into other media that led them to think why not adapt this type of technology for use in fertility clinics
Their intended first product, called Mojo Pro, is still pending certification as a medical device in the EU, for example
But the plan, should everything go to plan, is to get it to market next fall, starting in the UK.This product, a combination of microscopy
hardware and AI software, will be sold to fertility clinics (under a subscription model) to offer an analysis service consisting of a sperm
computer vision analysis system is focused on sperm counts, automating what Taha says is currently a manual process, as well as assessing
product is to look at the sperm and say if this man experiences infertility or not
Then, through looking at this, the system on Mojo Pro will tell us what is the sperm count, what is the sperm mobility (how fast they move)
if the sample is needed for IVF]
Now we ensure that good sperm is being selected
Good sperm have green boxes around them, bad sperm have red boxes around them so they can pick up through their current techniques the sperm
the business is to understand much more about the role that individual sperm and eggs play in yielding a healthy (or otherwise) embryo and
likely also incorporating genetic testing to screen for diseases).He points out that in many markets couples are choosing to conceive later
The big vision, therefore, is to develop new assisted reproductive technologies that can support older couples to conceive healthy
But when you hit later ages, 30 or 40, we face biological deficiencies which means the quality of the eggs are not good any more, the
What happens if this couple have the possibility of the sperm of the man to be shipped somewhere, the egg of the woman to be shipped
somewhere and they get fertilized using high end technology, and they get informed once the embryo is ready to be implanted
consumer-facing way where we ensure people have healthy babies
And this is where we see ART can actually be the way to procreate at later stages in order to ensure that the baby is healthy then there
start flowing via customers of the first product they expect to be able to start gathering data (with permission) to support further
co-founders actively started building the company in January 2018, taking in some angel investment, along with government grants from France
to the UK ahead of launching Mojo Pro.In the short term the hope is to attract clinics to adopt the Mojo Pro subscription service as a way
for them to serve more customers, while potentially helping couples reduce the number of IVF cycles they have to go
streamline laboratory processes in order to help the 180M people who have fertility problems have access to fertility at an affordable price
